DE2730762A1 - Verfahren zur herstellung des prostaglandins a tief 2 und bestimmter derivate desselben - Google Patents
Verfahren zur herstellung des prostaglandins a tief 2 und bestimmter derivate desselbenInfo
- Publication number
- DE2730762A1 DE2730762A1 DE19772730762 DE2730762A DE2730762A1 DE 2730762 A1 DE2730762 A1 DE 2730762A1 DE 19772730762 DE19772730762 DE 19772730762 DE 2730762 A DE2730762 A DE 2730762A DE 2730762 A1 DE2730762 A1 DE 2730762A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- product
- iii
- products
- prostaglandin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- BGKHCLZFGPIKKU-UHFFFAOYSA-N (13E,15S)-15-hydroxy-9-oxo-prosta-10,13-dienoic acid Natural products CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(O)=O BGKHCLZFGPIKKU-UHFFFAOYSA-N 0.000 title description 3
- -1 alkyl radical Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 3
- DYYLCPSSSFWEEA-UHFFFAOYSA-N 4-methylbenzenesulfinyl chloride Chemical compound CC1=CC=C(S(Cl)=O)C=C1 DYYLCPSSSFWEEA-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- HCBPHBQMSDVIPZ-UHFFFAOYSA-N methylcyclohexatriene Chemical compound CC1=CC=C=C[CH]1 HCBPHBQMSDVIPZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000000047 product Substances 0.000 description 28
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 150000003180 prostaglandins Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 230000003182 bronchodilatating effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- WJCXADMLESSGRI-UHFFFAOYSA-N phenyl selenohypochlorite Chemical compound Cl[Se]C1=CC=CC=C1 WJCXADMLESSGRI-UHFFFAOYSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MYHXHCUNDDAEOZ-FOSBLDSVSA-N prostaglandin A2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O MYHXHCUNDDAEOZ-FOSBLDSVSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003033 spasmogenic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7620769A FR2357542A1 (fr) | 1976-07-07 | 1976-07-07 | Procede de preparation de la prostaglandine a2 et de certains de ses derives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2730762A1 true DE2730762A1 (de) | 1978-01-12 |
Family
ID=9175362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772730762 Withdrawn DE2730762A1 (de) | 1976-07-07 | 1977-07-07 | Verfahren zur herstellung des prostaglandins a tief 2 und bestimmter derivate desselben |
Country Status (13)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338844A (en) * | 1989-10-19 | 1994-08-16 | Teijin Limited | 2-substituted-2-cyclopentenone compound and anticancer agent and bone formation accelerator comprising same as active ingredient |
| AU636675B2 (en) * | 1989-10-19 | 1993-05-06 | Teijin Limited | 2-substituted 2-cyclopentenone and carcinostatic agent and osteogenesis promoter containing the same as active ingredient |
| JP6739754B2 (ja) | 2015-03-09 | 2020-08-12 | 三菱瓦斯化学株式会社 | ジアミノジシクロヘキシルメタンの異性化方法 |
-
1976
- 1976-07-07 FR FR7620769A patent/FR2357542A1/fr active Granted
-
1977
- 1977-06-16 SE SE7706998A patent/SE420091B/xx unknown
- 1977-06-20 HU HU77RO933A patent/HU178334B/hu unknown
- 1977-07-05 NL NL7707458A patent/NL7707458A/xx not_active Application Discontinuation
- 1977-07-06 CA CA282,191A patent/CA1087614A/fr not_active Expired
- 1977-07-06 DK DK303977A patent/DK303977A/da not_active Application Discontinuation
- 1977-07-06 BE BE179126A patent/BE856545A/xx not_active IP Right Cessation
- 1977-07-06 IE IE1407/77A patent/IE45609B1/en unknown
- 1977-07-06 LU LU77693A patent/LU77693A1/xx unknown
- 1977-07-07 JP JP8050777A patent/JPS537649A/ja active Pending
- 1977-07-07 DE DE19772730762 patent/DE2730762A1/de not_active Withdrawn
- 1977-07-07 GB GB28566/77A patent/GB1538037A/en not_active Expired
- 1977-07-07 CH CH840477A patent/CH622247A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE45609B1 (en) | 1982-10-06 |
| LU77693A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-01-31 |
| CH622247A5 (en) | 1981-03-31 |
| SE7706998L (sv) | 1978-01-08 |
| NL7707458A (nl) | 1978-01-10 |
| FR2357542A1 (fr) | 1978-02-03 |
| JPS537649A (en) | 1978-01-24 |
| IE45609L (en) | 1978-01-07 |
| SE420091B (sv) | 1981-09-14 |
| BE856545A (fr) | 1978-01-06 |
| HU178334B (en) | 1982-04-28 |
| FR2357542B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1979-07-06 |
| GB1538037A (en) | 1979-01-10 |
| CA1087614A (fr) | 1980-10-14 |
| DK303977A (da) | 1978-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2649753A1 (de) | Verfahren zur herstellung von steroiden | |
| DE2115718A1 (de) | Verfahren zur Herstellung von penta cyclischen Alkaloiden | |
| DE2300107C2 (de) | Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen | |
| DE1695753B2 (de) | Verfahren zur Herstellung von 6,6disubstituierten 2,2-Dimethyl-4-oxopiperidinen | |
| DE2730762A1 (de) | Verfahren zur herstellung des prostaglandins a tief 2 und bestimmter derivate desselben | |
| DE3418382A1 (de) | Verfahren zur herstellung von 1,8-dihydroxy-10-acyl-9-anthronen | |
| DE2652685C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EP0123113B1 (de) | Chromon- und Thiochromon-8-aldehyde, sowie ein Verfahren zu ihrer Herstellung | |
| DE2806687A1 (de) | Verfahren zur herstellung von steroiden und dabei verwendete zwischenprodukte | |
| DE2364706A1 (de) | Prostansaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| DE2641736A1 (de) | Verfahren zur herstellung von phosphonsaeureestern | |
| DE3040200C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| AT346844B (de) | Verfahren zur herstellung von neuen oxazolderivaten | |
| DE4107121C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EP0834506B1 (de) | Verfahren zur Herstellung von (9alpha, 13alpha, 14alpha)-1-(3-Methoxymorphinan-17-yl)alkanonen | |
| DE825408C (de) | Verfahren zur Herstellung von 7-Dehydrothiosterinen und ihren Derivaten | |
| DE3136987A1 (de) | Verfahren zur herstellung von 3-keto-5-oxy-cyclopentenen | |
| DE2256866C3 (de) | Verfahren zur Herstellung von 17 alpha- oder 17beta-Hydroxy-Verbindungen der 20-Ketopregnan- oder -17alpha-pregnanreihe | |
| DE19826669B4 (de) | Verfahren zur Herstellung von Pyrazolen | |
| AT253141B (de) | Verfahren zur Herstellung von neuen Steroiden | |
| DD202162A5 (de) | Verfahren zur herstellung von derivaten des tetrahydro-5,6-7,7a 4h-thieno (3,2-c) pyridinons-(2) | |
| DE1815788A1 (de) | 4,5-substituierte N-Oxy- und Hydroxyhydoimidazole | |
| DE1216860B (de) | Verfahren zur Herstellung von bitertiaeren beta-Diolen | |
| DE1274125B (de) | Verfahren zur Herstellung von gegebenenfalls ringsubstituierten und Ringdoppelbindungen aufweisenden 17ª‰-Acetoacetoxysteroiden | |
| DE2505303A1 (de) | Epimerisationsverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |